scorecardresearch
Add as a preferred source on Google
Friday, December 12, 2025
TopicHip implants

Topic: Hip implants

When a woman’s Johnson & Johnson hip implant turned out to be ‘faulty product’

Kaunain Sheriff M -
In 'The Johnson & Johnson Files', Kaunain Sheriff M tells the story of how the ASR hip implant scandal was uncovered in India and how the company was brought to justice.

Johnson & Johnson directed to pay Rs 25 lakh each to 67 patients for faulty hip implants

PTI -
The Delhi High Court said it hadn't examined the controversy so this payment won't limit patients from seeking further compensation.

Shaken by J&J faulty implants, govt to regulate eight more medical devices

Himani Chandna -
According to the Union Health Ministry's internal estimates, over 80 per cent of the Indian medical device market is unregulated.

Supreme Court ends case against US-based pharma J&J for faulty hip implants

PTI -
The Centre has formulated a scheme to ensure compensation upto Rs 1.22 crore to patients with the faulty hip implants.

J&J says India doesn’t have compensation law, moves Delhi HC against Modi govt

Himani Chandna -
Johnson & Johnson says govt's compensation formula for 'faulty' hip implants is ‘absolutely one-sided’. Centre rushes to Supreme Court.    

Patients hurt by faulty Johnson & Johnson hip implants to begin getting damages soon

Himani Chandna -
The government has sent Johnson & Johnson the formula devised to compensate patients for the faulty hip implants. The firm has sought some time to respond.

Govt approves Rs 30 lakh to Rs 1.20 crore compensation for faulty J&J hip implants

Himani Chandna -
Compensation for the faulty J&J hip implants will be the first ever highest paid relief to disabled patients in India, says Drug Controller General of India.

Modi govt seals compensation J&J could pay for ‘faulty’ hip implants — Rs 30 lakh minimum

Himani Chandna -
Modi govt frames compensation formula for J&J by tweaking India's clinical trial rules. Now, upper limit is likely to be set at over Rs 1 cr.

Hip implants dent brand Johnson & Johnson, patients begin questioning other devices

Himani Chandna -
Doctors say Johnson & Johnson's hip implant controversy is causing concern among Indian patients fitted with other devices from the company.

Johnson & Johnson, Modi govt at odds over compensation for faulty hip implants

Himani Chandna -
Government says Johnson & Johnson has put it 'in writing' that it will pay aid but firm remains vague in its response on the subject.

On Camera

YourTurn

Opinion

IndiGo cancellations made TV news do the unexpected — question the Modi government

Shailaja Bajpai -
Republic TV was the harshest of them all: “The (civil aviation) minister has done a bad job,” said prime time anchor Arnab Goswami.

Why electoral ‘reform’ is cause for worry—the Modi govt uses it to cement political hold

The world’s biggest trade deal is in the making. India and EU must close it now

Economy

IndiGo’s profits dipped, most airlines sunk into losses last fiscal even as flier numbers soared

Udit Bubna -
Despite growing passenger volume, 11 out of 14 carriers reported losses in 2023-24. IndiGo recorded profit of Rs 8,167 crore, which reduced to Rs 7.253 crore in 2024-25.

Defence

US clears $686-mn package to breathe fresh life into Pakistani F-16s

Vaibhav Pant -
Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).

National Interest

Asim Munir & Pakistan’s Failed Marshal Doctrine

Shekhar Gupta -
None of Pakistan’s PMs has lasted 5 years. That the current PM has given Asim Munir 5 years shows that of all military dictatorships history has seen, Pakistan’s is most creative.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.